Related Experiment Video
Updated: Feb 13, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer
Wen-Kun Bai1, Wei Zhang1, Bing Hu1
1Department of Ultrasound in Medicine, Shanghai Jiao Tong University Affiliated 6th People's Hospital, Shanghai Institute of Ultrasound in Medicine, Shanghai, China.
Purpose:
Prostate cancer (PCa) patients often have dendritic cell (DC) function defects, but the mechanism is not clear. The aim of this study was to detect the effect of vascular endothelial growth factor (VEGF) in mature DCs.
Patients And Methods:
In this study, we chose 30 PCa patients, 10 prostatic intraepithelial neoplasia (PIN) patients and 30 benign prostatic hyperplasia (BPH) patients, and compared the composition of peripheral blood T cells, the composition and function of local dendritic cells in prostate tissue, and the density of local VEGF.
Results:
The results showed that the numbers of total DCs, mature and functional DCs, and CD4+ T cells were inhibited in PCa, and the inhibitory effect was enhanced with increased malignancy. In addition, the infiltration density of VEGF-positive cells was increased in PCa, and this increase was associated with an increased malignant degree of PCa. The inhibition of tumor immunity in patients with PCa is achieved by inhibiting the function of dendritic cells.
Conclusion:
VEGF plays an important role in the inhibition of the maturation and function of dendritic cells, and this inhibition is gradually increased with an increasing malignant degree of PCa.
Insights
Vascular endothelial growth factor (VEGF) inhibits dendritic cell (DC) function in prostate cancer (PCa). This inhibition worsens with increasing PCa malignancy, impairing anti-tumor immunity.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Prostate cancer (PCa) is associated with impaired dendritic cell (DC) function.
- The underlying mechanisms for these DC defects in PCa remain unclear.
Purpose of the Study:
- To investigate the role of vascular endothelial growth factor (VEGF) in the function of mature dendritic cells (DCs) within the context of prostate cancer.
Main Methods:
- Comparative analysis of peripheral blood T cells, prostate tissue dendritic cells (composition and function), and local VEGF density.
- Study included patients with PCa, prostatic intraepithelial neoplasia (PIN), and benign prostatic hyperplasia (BPH).
Main Results:
- PCa patients exhibited reduced numbers of total, mature, and functional DCs, along with decreased CD4+ T cells.
- VEGF-positive cell infiltration increased with higher PCa malignancy.
- Inhibition of DC function was identified as a mechanism for suppressed anti-tumor immunity in PCa.
Conclusions:
- VEGF significantly inhibits dendritic cell maturation and function.
- The inhibitory effect of VEGF on DCs intensifies with increasing prostate cancer malignancy.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: Osmolarity
Transcription Factors
Meristems and Plant Growth

